Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Focus Group participants (patients):
- People who have been diagnosed with a genetic predisposition to breast cancer, ductal carcinoma in situ, or any invasive cancer, confirmed through medical records
- People aged 18 or older
- People who are considering breast reconstruction surgery after mastectomy
Main trial participants (patients):
- People who have been diagnosed with a genetic predisposition to breast cancer, ductal carcinoma in situ, or any invasive cancer, confirmed through medical records
- People aged 18 or older
- People who are considering breast reconstruction surgery after mastectomy
- People who have a consultation appointment already scheduled with a plastic surgery provider
Main trial participants (physicians/surgeons):
- Surgeons whose practice consists of breast reconstruction surgery for more than half of their cases in the previous calendar year
Who may not be able to join:
Focus Group participants (patients):
- People who are not considering breast reconstruction surgery after mastectomy
- People who are not proficient in English
Main trial participants (patients):
- People who are not considering breast reconstruction surgery after mastectomy
- People whose breast cancer has come back or spread to other parts of the body
- People who are male
- People who are not proficient in English
Main trial participants (physicians/surgeons):
- Surgeons for whom breast reconstruction makes up less than half of their surgical caseload
- Surgeons who are not proficient in English
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Evan Matros, MD, Memorial Sloan Kettering Cancer Center
Phone: 646-608-8044
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility determined by participant accrual
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.